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Factors associated with early failure of
infrainguinal lower extremity arterial bypass
Niten Singh, MD, Anton N. Sidawy, MD, Kent J. DeZee, MD, Richard F. Neville, MD,
Cameron Akbari, MD, and William Henderson, PhD, Washington, DC
Objectives: We analyzed the Veterans Affairs (VA) National Surgical Quality Improvement Program (NSQIP), a large
clinical database, to investigate which factors, other than technical, were associated with a higher incidence of early graft
failure in infrainguinal bypass.
Methods: Data are prospectively collected in NSQIP from 123 participating VA Medical Centers. All patients from 1995
to 2003 in the NSQIP database who underwent infrainguinal arterial bypass were identified by Current Procedural
Terminology (CPT) codes (CPT is a registered trademark of the American Medical Association, Chicago, Ill, Copyright
2007). Data for 30-day graft failure were evaluated by univariate analysis, and multivariate logistic regression was used
to control for possible confounders.
Results: The NSQIP database identified 14,788 patients who underwent infrainguinal lower extremity arterial bypasses
during the study period, and 723 acute graft failures (4.9%) occurred. On multivariate analysis, compared with patients
aged >70 years, patient ages of <50 and 51 to 60 years were significantly associated with early graft failure (odds ratio
[OR], 2.2; 95% confidence interval [CI], 1.6-3.0; P< .001; OR, 1.4; 95% CI, 1.2-1.6, P< .001; respectively); age range
of 61 to 70 years was not significantly associated with early graft failure. African American race was also associated with
early graft failure, and diabetes mellitus had a negative association with early graft failure (OR, 1.4; 95% CI, 1.3-1.5;
P< .001; OR, 0.72; 95% CI, 0.58-0.89; P .002; respectively). Although smoking was a significant factor for acute graft
failure on univariate analysis, it was not significant on multivariate analysis. Multivariate analysis of the type of procedure
performed revealed that femoral to popliteal bypass with vein or prosthetic graft was associated with better early graft
patency than any of the tibial vessel bypass procedures except for popliteal to tibial bypass with autogenous vein.
Conclusion: These data suggest that factors other than technique have an effect on the 30-day graft failure rates of
infrainguinal bypasses. These results help the vascular surgeon to predict more accurately early bypass failure rates while
planning the procedure and counseling patients about its prognosis. ( J Vasc Surg 2008;47:556-61.)Patency of infrainguinal arterial bypass grafts is a con-
stant issue of concern for the vascular surgeon. A failed
infrainguinal bypass is associated with poor prognosis for
the limb in question, particularly if the graft was initially
placed for limb salvage.1-3 This concern regarding patency
has led many investigators to identify characteristics associ-
ated with infrainguinal bypass failure, leading to the recom-
mendations of increased surveillance and preemptive inter-
ventions on vein grafts.4,5
Graft failures are traditionally grouped into early and late.
Early or acute failure (30 days) is believed to be generally
related to technical issues or problems related to inflow or
outflow arteries and the adequacy of the conduit.6 Other
factors may result in early graft failure, however. We have
recently published our findings regarding the effects of the
type of anesthesia on graft failure and found that general
endotracheal anesthesia is associated with a higher incidence
of early graft failure.7 Late failure, or failure especially 6
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556months, is usually related to intimal hyperplasia or progression
of the atherosclerotic process proximal or distal to bypass
location.
Prior publications exploring early graft failure have been
from smaller, single-institution series. In this study, we used a
large, multi-institutional, and well-controlled database in an
attempt to identify patient and procedure characteristics that
may have an effect on early graft failure.
METHODS
Database. Dedicated staff collects detailed perioperative
data from Veterans Affairs (VA) Medical Centers in the VA
National Surgical Quality Improvement Program (NSQIP)
database. This database has been described in detail in prior
reports.8 In brief, 123 VA Medical Centers in the United
States participate in the NSQIP program by prospectively
collecting perioperative data and 30-day specific outcomes on
surgical patients.
Sample selection. Approval to conduct this study was
obtained from the Institutional Review Board (IRB) of the
Washington, DC VA Medical Center. We queried the
database using Current Procedural Terminology (CPT)
codes (American Medical Association, Chicago, Ill) for
infrainguinal lower extremity arterial bypass procedures
from January 1, 1995, to December 31, 2003. The queried
CPT codes are listed in Table I. We analyzed the data
correlating 30-day graft failure, which was an outcome
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acteristics and comorbid conditions.
Baseline patient demographic characteristics and
comorbid conditions. Patient baseline characteristics in-
cluded age, sex, and race (African American vs any other
race). Clinical characteristics included in the database were
history of stroke (with and without a residual deficit),
congestive heart failure (CHF), chronic obstructive pulmo-
nary disease (COPD), diabetes mellitus (none vs non-
insulin-dependent vs insulin-dependent), need for any as-
sistance with activities of daily living (ADL), American
Society of Anesthesiologists (ASA) classification, anesthesia
type (spinal vs general endotracheal anesthesia vs epidural),
and annual procedure volume at the individual hospital.
Current smoking is defined in the NSQIP database as
smoking cigarettes 1 year of the surgery and current
alcohol use as 28 alcoholic drinks 2 weeks of surgery.
Lastly, the database included several preoperative labora-
tory variables on most patients, including serum albumin,
hematocrit, white blood cell count (WBC), platelet count,
prothrombin time (PT), partial thromboplastin time
(PTT), creatinine, and blood urea nitrogen (BUN).
Statistical analysis. All of the baseline characteristics
were screened for inclusion in the multivariate model using
2 or the Student t test, as appropriate. Any univariate
association with a value of P  .25 was included in the
initial multivariate model. Multivariate analysis was per-
formed using multivariate logistic regression with hier-
archical modeling to account for clustering by region of
the country. The final model was checked for goodness
of fit using the Hosmer-Lemeshow method. All values of
P were two tailed with a significance level of .05. Analy-
ses were conducted using STATA 8.0 software (Stata-
Corp, College Station, Tex).
RESULTS
We identified 14,788 patients who had lower extremity
surgical bypass procedures during the study period. Base-
line demographics are presented in Table II. The patients
had the usual demographic pattern for infrainguinal arterial
occlusive disease. As would be expected in a VA population,
99% of the patients were men. There were 723 graft failures
Table I. Current Procedural Terminology (CPT)
codes queried
CPT code Procedure
35556 Femoral to popliteal bypass with vein
35566 Femoral to tibial vessel bypass with vein
35571 Popliteal to tibial vessel bypass with vein
35583 Femoral to popliteal in situ
35585 Femoral to tibial vessel in situ
35587 Popliteal to tibial vessel in situ
35656 Femoral to popliteal with prosthetic
35666 Femoral to tibial vessel with prosthetic
35671 Popliteal to tibial vessel with prosthetic(4.9%) during the 30-day postoperative period.The following clinical factors were not found to be signif-
icantly associated with early graft failure by univariate or mul-
tivariate analysis: sex, history of stroke, alcohol use, history of
CHF, history of COPD, ASA class, need for any ADL assis-
tance, and the volume of procedures preformed at the indi-
vidual hospital. In addition, the following laboratory values
were not found to be associated with early graft failure: albu-
min,WBC, platelet count, PT, PTT, BUN, or creatinine. The
remaining variables discussed in the next sections were found
tobe associatedwith graft failure in themultivariatemodel. All
odds ratios (OR) reported were adjusted for anesthesia type,
age, diabetic status, African American race, hematocrit, and
operation configuration.
Age. Patients were divided into four groups by age:
50, 51 to 60, 61 to 70, and70. Patients aged50 years
were found to have an 8.2% early graft failure rate, which
was significantly higher (P  .001) than the failure rate of
4.4% in patients 70 years. In addition, when placed in a
multivariate model with age 70 years as the referent,
patients 50 years had two times the odds of graft failure
and patients aged 51 to 60 years had a 40% higher chance of
graft failure. In contrast, patients aged 61 to 70 years did
not have significantly higher odds of graft failure compared
to those 70 years (Table III).
Race. A total of 173 (6.7%) graft failures occurred in
2578 bypass procedures performed in African Americans. In
comparison, 550 (4.5%) graft failures occurred in 10,602
procedures performed in Caucasians. In our multivariate
model, we combined all other races (1608 patients who were
Hispanic, Asian, and others) with Caucasians because these
individual races were too small in number for meaningful
multivariate analysis. When we compared the African Ameri-
can group with Caucasian patients, we found that African
Americans had an increased OR of 1.4 (95% CI, 1.3-1.5) in
Table II. Demographics
Variable No (%) or average value
Male 14,640 (99)
Age, mean  SD years 66  9.7
Stroke
With neurologic deficit 1477 (10)
Without neurologic deficit 976 (6.6)
Alcohol use 1715 (11.6)
History of smoking 7837 (53)
History of CHF 680 (4.6)
History of COPD 2706 (18.3)
Diabetes mellitus type
Insulin-dependent 3652 (24.7)
Oral hypoglycemic medication 2898 (19.6)
African American race 2578 (17.4)
Albumin, g/dL 3.6
Creatinine, mg/dL 1.4
Blood urea nitrogen, mg/dL 19.4
Hematocrit, % 38
Platelet count,  103 L 265
Prothrombin time, seconds 12.8
Partial thromboplastin time, seconds 33.0
White blood count,  103 L 8.8the likelihood of having early graft failure (Table IV).
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tients, 3652 patients with insulin-dependent diabetes mel-
litus, and 2898 patients with non-insulin-dependent diabe-
tes. There were 448 early graft failures in the non-diabetic
patients (5.5%), 161 early graft failures in patients with
insulin-dependent diabetes (4.4%), and 114 early graft
failures in patients with non-insulin-dependent diabetes
(4.0%). The higher percentage of failures in the nondiabetic
patients was significant on univariate analysis (P .003). In
addition, multivariate analysis using nondiabetic patients as
the referent group showed a 28% lower chance of graft
failure in patients requiring insulin and in those taking oral
medication, and both these comparisons were statistically
significant (Table V).
Hematocrit. The mean hematocrit was 38% for the
group, and patients with a higher hematocrit did better
with regards to early graft failure vs those with a lower
hematocrit. Indeed, for every 1% decrease in the hematocrit
38%, the odds of graft failure increased by 2% (OR, 0.98;
95% CI, 0.98-0.99; P  .001).
Smoking. Patients with a history of smoking had an
Table III. Age and early graft failure
Age (years)
Univariate analysis of age and graf
Bypasses, no. Failures, no.
51 1035 85
51-60 3248 171
61-70 5354 242
70 5151 225
Total 14,788 723
CI, Confidence interval; OR, odds ratio.
aAge 70 as reference.
bOdds ratios adjusted for anesthesia type, diabetic mellitus, African Americ
cP  .001 on 2.
Table IV. Race and early graft failure
Race Bypasses, no. Failures, no.
African American 2578 173
All other racesc 12,210 550
CI, Confidence interval; OR, odds ratio.
aOdds ratios adjusted for anesthesia type, age, diabetes mellitus, hematocrit
bP  .001 on 2 analysis.
cCaucasian, 10,602 patients; Hispanics, Asians, other races, 1608 patients.
Table V. Diabetic status and early graft failure
Diabetic status Bypasses, no. Failures, no.
Nondiabetic 8238 448
Insulin 3652 161
Oral medication 2898 114
CI, Confidence interval; OR, odds ratio.
aOdds ratios adjusted for anesthesia type, age, African American race, hema
bP  .003 on 2 analysis.early failure rate of 5.4%, and nonsmokers had a graft failurerate of 4.4%. On univariate analysis this difference was
significant (P  .009); however, when placed in our mul-
tivariate model, the difference was not found to be statisti-
cally significant.
Bypass configuration and early graft failure
Popliteal bypass. A total 8310 femoral–popliteal ar-
tery bypass procedures were done. In 4010 patients, the
bypass was done with translocated or reversed vein (TLV/
RSV), and 154 had acute graft failures (3.8%). An in situ
femoral–popliteal artery bypass was done in 795 patients,
and 32 had acute graft failures (4.0%). Finally, 3505 pa-
tients underwent a femoral–popliteal artery bypass with
prosthetic grafts and had 125 early graft failures (3.6%).
The difference between these three graft types on univariate
or multivariate analysis was not statistically significant (Ta-
ble VI). The difference in graft failure between above and
below the knee configurations could not be analyzed be-
cause the group of femoral popliteal bypasses in NSQIP
included both types.
Infrapopliteal bypass. There were 6478 tibial vessel
re
Multivariate logistic regression analysis of
age and graft failurea
Failure, % ORb 95% CI P
8.21c 2.2 1.6-3.0 .001
5.26c 1.4 1.2-1.6 .001
4.52 1.1 0.96-1.3 .150
4.37 Ref Ref Ref
4.9
, hematocrit, and operation type.
Failure, % ORa 95% CI P
6.71b 1.4 1.3-1.5 .001
4.5 Ref Ref Ref
operation type.
Failure, % ORa 95% CI P
5.45 Ref Ref Ref
4.42b 0.72 0.58-0.89 .002
4b 0.72 0.58-0.89 .002
and operation type.t failu
an race, andtocrit,bypass procedures included. Femoral–tibial artery bypass
erican
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incidence of early graft failure (8.2%). In contrast, autog-
enous vein popliteal–tibial artery bypass was associated
with the lowest incidence of early graft failure (4.7%). In
addition, early graft failure occurred in only four (3.7%)
of the 109 popliteal–tibial vessel bypasses with prosthetic
graft; however, this group was too small to place within
the multivariate model. Thus, in the multivariate analysis
using femoral–popliteal artery bypass as the referent
group, all tibial artery bypass procedures, with the excep-
tion of popliteal–tibial artery bypass with vein, were
associated with higher odds of 30-day failure (Table
VII). Adjuvant techniques used to improve patency of
prosthetic infrapopliteal bypasses, such as distal arterio-
venous fistula or addition of vein cuff or patch at distal
anastomosis, could not be queried in NSQIP because
add-on codes for these techniques were only recently
added to CPT.
DISCUSSION
Several reports in the literature have focused on tech-
nical issues and underlying physiologic factors as the culprit
in early infrainguinal bypass failure.9-15 In this study, we
were able to identify from a large database the following
factors to be associated with a higher risk of early graft
thrombosis: patients aged 60 years, African American pa-
tients, nondiabetic patients, and patients with lower hemato-
crit levels. In addition, although no difference in the risk of
early graft failure was found between femoral–popliteal bypass
Table VI. Femoral to popliteal bypass: vein vs prosthetic
Procedure Total Graft failu
Fem-pop bypass
With vein (RSV/TLV)b 4010 154
In situ 795 32
With prosthetic 3505 125
CI, Confidence interval; OR, odds ratio; RSV, reversed saphenous vein; TL
aOdds ratios adjusted for anesthesia type, age, diabetic mellitus, African-Am
bAll values are nonsignificant on 2 analysis.
Table VII. Tibial vessel bypass and early graft failure
Procedure Total Graft failure, no
With vein (RSV/TLV)
Femoral–tibial 3344 211
Popliteal-tibial 848 40
In situ
Femoral–tibial 1312 90
Popliteal–tibial 192 12
With prosthetic
Femoral–tibial 673 55
Popliteal–tibial 109 4
CI, Confidence interval; OR, odds ratio; RSV, reversed saphenous vein; TL
aOdds ratios adjusted for anesthesia type, age, diabetic mellitus, African Am
bP  .001 on 2 analysis comparison with femoral–popliteal bypass.
cToo few for multivariate analysis.with vein or prosthetic grafts, all types of tibial vessel bypassprocedures were associated with a higher chance of early graft
failure compared with femoral–popliteal artery bypass with
vein, with the exception of a popliteal–tibial vessel bypass with
autogenous vein.
The finding in this study that patients aged 60 years,
and particularly those 50 years, have higher incidence of
early graft failure has important clinical implications on the
management of lower extremity vascular disease. The term
virulent disease has been used in smaller series to describe an
aggressive form of atherosclerosis that appears in young
patients; some reports have indicated that such virulent
disease maybe associated with an underlying hypercoagula-
ble state in these patients.16 Numerous studies have found
a poor prognosis for this virulent disease because these
patients have higher rates of graft failure, reoperations, and
amputations.17-23
Saltzberg et al17 studied outcomes in lower extremity
revascularization in young diabetic patients and found a
30-day graft failure rate of 11.1%. They postulated that this
may be a result of a more aggressive treatment taken in
these younger patients with an attempt to perform a bypass
to a suboptimal distal target rather than perform a primary
amputation.17 Although this report blamed the inferior
results on aggressive surgical behavior, other investigators
have attempted to identify other risk factors for graft failure
in young patients, such as hypercoagulable states. Eldrup-
Jorgenen et al24 studied 20 patients aged51 who under-
went a lower extremity bypass. Four of these patients had a
bypass failure, and all four had a known hypercoagulable
arly graft failure
Percent ORa 95% CI P
3.8 Ref Ref Ref
4.0 1.1 0.99-1.3 .07
3.6 0.91 0.74-1.1 .34
nslocated saphenous vein.
race, hematocrit, and operation type.
Percent ORa 95% CI P
6.3b 1.7 1.5-2.0 .001
4.7 1.3 0.85-2.0 .22
6.9b 1.9 1.7-2.2 .001
6.3b 1.7 1.2-2.3 .001
8.2b 2.2 1.7-2.8 .001
3.7 . . .c . . . . . .
nslocated saphenous vein.
race, hematocrit, and operation type.and e
re
V, tra.
V, tra
ericandisorder. Curi et al25 have also suggested that the grafts of
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term patency; in their series, patients with hypercoagulabil-
ity were also younger. Thus, younger patients presenting
with lifestyle-limiting claudication or tissue loss should be
evaluated for hypercoagulability before proceeding with
revascularization.26
Our study noted that African American patients were
more likely to have an early graft failure compared with all
other races. In a study by Huber et al,27 African Americans
in Florida were significantly more likely to undergo ampu-
tation rather than revascularization compared with Cauca-
sians, and they concluded this was likely due to differences
in the severity of disease or disease distribution. More
recently, Chew et al28 found poorer primary patency and
limb salvage rates in African American patients, who had a
30-day graft failure rate of 12% compared with 5% in
Caucasians.
We have studied race as a risk factor in infragenicular
occlusive disease and found that when disease severity
scores were compared between Caucasians and African
Americans, African Americans presenting with symptom-
atic lower extremity peripheral arterial disease had more
advanced occlusive disease in the infragenicular distribu-
tion.29 It is possible that this advanced disease in this
distribution may lead to higher incidence of early graft
failure in this patient population.
Of interest was that patients with diabetes in our study
had a lower incidence of early graft failure compared with
nondiabetic patients. Other series have also shown that
diabetic patients have better outcomes after infrainguinal
bypass procedures.30,31 Pomposelli et al32 investigated
their experience with dorsalis pedis bypass procedures, 92%
of which were performed on diabetic patients, and found
the 30-day graft failure rate was 4.2%, which was almost
identical to our findings. They commented on the pattern
of disease frequently found in diabetic patients in whom the
aortoiliac segment and superficial femoral arteries are usu-
ally spared, thus allowing for more distal inflow sites and
shorter segments of vein conduit for the bypasses.
Similarly, Rutherford et al31 found in a series of patients
who were classified as difficult distal bypass procedures that
diabetic patients fared better with regards to patency com-
pared with nondiabetic patients. The diabetic patients in
that series had more autogenous vein grafts and less to-
bacco use, but even taking these variables into account,
diabetic patients who underwent femoral–tibial artery by-
pass with vein had an “unexplained advantage” with re-
gards to patency.
Patients with a higher hematocrit also had a lower
incidence of early graft failure. This may not be clinically
relevant, however, because the level of benefit for an in-
crease in the hematocrit by 1% (ie, 38% to 39%) was a
decrease in graft failure by only 2%. Thus, we believe that
although this difference is statistically significant, it may not
be clinically relevant.
Finally, we found that the incidence of early graft failure
was not significantly different for femoral–popliteal bypass
procedures done with either prosthetic or vein grafts. Nu-merous studies have found equivalent patency rates for
bypasses done with prosthetic and autogenous conduits in
the above knee position but worse patency in the below
knee position.33,34 Unfortunately, because the database is
queried by using CPT codes, we could not separate the
femoral–popliteal bypasses into above knee and below knee
popliteal artery targets for subgroup analysis. We also found
that all infrapopliteal bypass procedures had worse early
failure rates compared with femoral–popliteal bypass pro-
cedures performed with autogenous vein, with the excep-
tion of a popliteal–tibial artery bypass with vein. This may
be the result of a more distal inflow site requiring a shorter
segment of autogenous vein for the bypass. As expected,
the femoral–tibial vessel bypass with prosthetic grafts had
the highest early failure rate, 8.2%.
CONCLUSION
Although some of the patient factors identified in this
study cannot be modified, such as the patient’s diabetic status
or race, perioperative management could be adjusted with an
understanding of the risk of early graft failure posed by these
patients’ conditions. In a patient aged 50 years, optimal
nonoperative management and hypercoagulability studies
would be warranted before proceeding with an infrainguinal
bypass procedure. Although there is a tendency to operate
on young patients with claudication to return them to full
active walking status, this may not be the most appropriate
strategy in light of our results, and the surgeon should be
less rather than more aggressive in the surgical manage-
ment of these patients. Furthermore, bypass especially to
the tibial arteries should be strictly reserved for limb salvage
situations and every effort should be expended to use an
autogenous vein from the most available distal inflow
source. Considering these patient characteristics while for-
mulating treatment options and presenting their prognosis
to patients would optimize care of patients and their un-
derstanding of their disease and the proposedmanagement.
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